Daldoul Amira, Khechine Wieme, Bhiri Hanene, Ammar Nouha, Bouriga Rym, Krir Mohamed Wassim, Soltani Said, Zoukar Olfa, Rhim Mohamed Salah, Bouslah Sarra, Dimassi Sabrine, Abbess Ibtissem, Saidani Zahra, Zaied Sonia
Department of Medical Oncology, Fattouma Bourguiba University Hospital of Monastir, Tunisia. Email:
Asian Pac J Cancer Prev. 2018 Jun 25;19(6):1671-1675. doi: 10.22034/APJCP.2018.19.6.1671.
Background: Due to progress in medical care, the number of survivors from cancer has increased significantly during recent years and this raises the question of the quality of life (QoL), especially of the many women treated for a breast cancer. This paper focuses on correlations of QoL with anxiety and depression on the one hand and with socio demographic, anatomo-clinical and therapeutic parameters on the other. Methods: In this cross-sectional study, seventy patients were enrolled and filled in two auto-questionnaires, both in validated Arabic versions: The SF-36 for assessment of QoL and the Hospital Anxiety and Depression Scale (HAD-S) for evaluation of anxiety and depression. The statistical approaches used to determine predictive factors were bivariate correlations to determine relationships between quantitative variables, and T-tests and one-way Anova to analyze links between qualitative and quantitative variables. Results: The QoL of patients was altered with an SF-36 mean total score of 54.0 ± 22.7, and the alteration affects the different aspects. The mean scores for anxiety and depression in patients were 6.91 ± 4.72 and 6.24 ± 3.88, respectively. The results of this study suggested an association between the QoL and chemotherapy (p= 0.014) and its adverse effects (p=0.01), as well as anxiety (p= 0.0001) and depressive symptoms (p= 0.0001). Socio-demographic factors, the stage of the cancer, and surgery, radiotherapy or hormone therapy did not appear to have significant effects. Conclusion: The management of breast cancer patients needs a collaborative approach between oncologists, gynecologists, psychologist and psychiatrists.
由于医疗护理的进步,近年来癌症幸存者的数量显著增加,这引发了生活质量(QoL)的问题,尤其是众多接受乳腺癌治疗的女性的生活质量问题。本文一方面关注生活质量与焦虑和抑郁的相关性,另一方面关注其与社会人口统计学、解剖临床学及治疗参数的相关性。方法:在这项横断面研究中,招募了70名患者,他们填写了两份经过验证的阿拉伯语版本的自填式问卷:用于评估生活质量的SF - 36问卷和用于评估焦虑和抑郁的医院焦虑抑郁量表(HAD - S)。用于确定预测因素的统计方法包括:用于确定定量变量之间关系的双变量相关性分析,以及用于分析定性和定量变量之间联系的T检验和单因素方差分析。结果:患者的生活质量有所改变,SF - 36平均总分是54.0 ± 22.7,且这种改变影响了不同方面。患者焦虑和抑郁的平均得分分别为6.91 ± 4.72和6.24 ± 3.88。本研究结果表明生活质量与化疗(p = 0.014)及其不良反应(p = 0.01)、焦虑(p = 0.0001)和抑郁症状(p = 0.0001)之间存在关联。社会人口统计学因素、癌症分期以及手术、放疗或激素治疗似乎没有显著影响。结论:乳腺癌患者的管理需要肿瘤学家、妇科医生、心理学家和精神科医生之间的协作方法。